These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7845750)

  • 41. Evaluation of Bayesian predictability of vancomycin concentration using population pharmacokinetic parameters in pediatric patients.
    Ohnishi A; Yano Y; Ishibashi T; Katsube T; Oguma T
    Drug Metab Pharmacokinet; 2005 Dec; 20(6):415-22. PubMed ID: 16415526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical evaluation of vancomycin dosage in pediatric oncology patients.
    Sanders SJ; Bijleveld YA; Sinkeler F; Kemper EM; Pajkrt D; van de Wetering M; van Eijkelenburg NK; Mathôt RA
    Pediatr Infect Dis J; 2014 Jul; 33(7):731-3. PubMed ID: 24445830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
    Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
    J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vancomycin dosing in haemodialysis patients and Bayesian estimate of individual pharmacokinetic parameters.
    Keller F; Hörstensmeyer C; Looby M; Borner K; Pommer W; Erdmann K; Giehl M
    Int J Artif Organs; 1994 Jan; 17(1):19-26. PubMed ID: 8188395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
    Pea F; Porreca L; Baraldo M; Furlanut M
    J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
    Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
    Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Individualizing vancomycin dosing regimens: an evaluation of two pharmacokinetic dosing programs in critically ill patients.
    Fernández de Gatta MM; Fruns I; Domínguez-Gil A
    Pharmacotherapy; 1994; 14(2):196-201. PubMed ID: 8197039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement.
    Fan-Havard P; Nahata MC; Bartkowski MH; Barson WJ; Kosnik EJ
    Chemotherapy; 1990; 36(2):103-8. PubMed ID: 2311439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bayesian and least-squares methods for vancomycin dosing.
    Uaamnuichai M; Day RB; Brater DC
    Am J Med Sci; 1987 Aug; 294(2):100-4. PubMed ID: 3631119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The association of elevated trough serum vancomycin concentrations with obesity.
    Richardson J; Scheetz M; O'Donnell EP
    J Infect Chemother; 2015 Jul; 21(7):507-11. PubMed ID: 25851852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infants.
    Lisby-Sutch SM; Nahata MC
    Eur J Clin Pharmacol; 1988; 35(6):637-42. PubMed ID: 3234472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computer dosing program for the initiation of vancomycin therapy.
    Ito MK; Duren LL; Simonian JS; Dreyfus-Vigil SD; Cookson TL
    Clin Pharm; 1993 Feb; 12(2):126-30. PubMed ID: 8453861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monitoring of serum vancomycin concentrations in pediatric patients with normal renal function.
    Khotaei GT; Jam S; SeyedAlinaghi S; Motamed F; Nejat F; Taghi M; Ashtiani H; Izadyar M
    Acta Med Iran; 2010; 48(2):91-4. PubMed ID: 21133000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
    Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population pharmacokinetics of vancomycin in Japanese pediatric patients.
    Yasuhara M; Iga T; Zenda H; Okumura K; Oguma T; Yano Y; Hori R
    Ther Drug Monit; 1998 Dec; 20(6):612-8. PubMed ID: 9853975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Empirical Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations.
    Thomas CA; Picone A; Menon S; Willis BC
    Pharmacotherapy; 2017 Nov; 37(11):1341-1346. PubMed ID: 28833385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vancomycin dosage in overweight and obese children.
    Miller M; Miller JL; Hagemann TM; Harrison D; Chavez-Bueno S; Johnson PN
    Am J Health Syst Pharm; 2011 Nov; 68(21):2062-8. PubMed ID: 22011985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.